2361 Stock Overview
Provides healthcare insight solutions for sales and marketing needs of medical product manufacturer clients in Mainland China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sinohealth Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$4.60 |
| 52 Week High | HK$6.00 |
| 52 Week Low | HK$3.62 |
| Beta | 0.20 |
| 11 Month Change | 15.00% |
| 3 Month Change | -3.36% |
| 1 Year Change | -8.91% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -14.18% |
Recent News & Updates
Shareholder Returns
| 2361 | HK Healthcare Services | HK Market | |
|---|---|---|---|
| 7D | 1.5% | 3.5% | 0.4% |
| 1Y | -8.9% | -11.2% | 12.0% |
Return vs Industry: 2361 exceeded the Hong Kong Healthcare Services industry which returned -11.2% over the past year.
Return vs Market: 2361 underperformed the Hong Kong Market which returned 12% over the past year.
Price Volatility
| 2361 volatility | |
|---|---|
| 2361 Average Weekly Movement | 5.8% |
| Healthcare Services Industry Average Movement | 7.8% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.9% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 2361 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2361's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 778 | Yushu Wu | ir.sinohealth.cn |
Sinohealth Holdings Limited provides healthcare insight solutions for sales and marketing needs of medical product manufacturer clients in Mainland China and internationally. The company operates through four segments: Smart Retail Cloud, Smart Decision Cloud, Smart Health Management Cloud, and Smart Medical Cloud. It engages in the research and development and provision of data insight solutions, data-driven publications and events, and software as a service (SaaS) product; research and development and the operation of Smart Medical Cloud under the business line of SaaS products; management of marketing and promotion services of innovative medicine; operation of SaaS products; provision of internet information and internet data center services; and engages in foreign-related market research business.
Sinohealth Holdings Limited Fundamentals Summary
| 2361 fundamental statistics | |
|---|---|
| Market cap | HK$1.88b |
| Earnings (TTM) | HK$103.05m |
| Revenue (TTM) | HK$441.51m |
18.3x
P/E Ratio4.3x
P/S RatioIs 2361 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2361 income statement (TTM) | |
|---|---|
| Revenue | CN¥410.78m |
| Cost of Revenue | CN¥173.70m |
| Gross Profit | CN¥237.08m |
| Other Expenses | CN¥141.20m |
| Earnings | CN¥95.87m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 57.71% |
| Net Profit Margin | 23.34% |
| Debt/Equity Ratio | 0% |
How did 2361 perform over the long term?
See historical performance and comparison